Phase Ii Study Of Bevacizumab Plus Uft/Lv In Elderly Patients With Metastatic Colorectal Cancer(J-Blue): Os Updated

Toshiki Masuishi, Mitsuo Shimada,Tomohiro Nishina,Toshikazu Moriwaki,Mitsuharu Ozeki,Yuji Negoro, Shunju Indo,Tadamichi Denda,Takashi Maeba,Ichinosuke Hyodo

ANNALS OF ONCOLOGY（2014）

引用 0|浏览0

暂无评分

摘要

Background: The elderly patients (pts) with metastatic colorectal cancer (mCRC) have been often left outside the clinical trials, and useful clinical data are limited. We showed that UFT/LV treatment for elderly pts was well-tolerated in the previous phase II study, and then evaluated the efficacy and safety of bevacizumab (Bmab) plus UFT/LV in the present study.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要